One-year healthcare utilization outcomes of two- versus one-injection start regimens of aripiprazole once-monthly in schizophrenia: a retrospective cohort study

The two-injection start (TIS) regimen of aripiprazole once-monthly (AOM) avoids the 14-day oral supplementation required with the one-injection start (OIS), but real-world evidence comparing their longer-term healthcare utilization outcomes in acutely hospitalized patients with schizophrenia remains limited. We retrospectively compared 131 patients hospitalized for an acute psychotic exacerbation of schizophrenia who initiated AOM via OIS ( n = 79) or TIS ( n = 52). Primary outcomes were time to first psychiatric rehospitalization and emergency room (ER) visit within 1 year. Analyses included Kaplan–Meier estimates, Cox models adjusted for age, sex, and baseline chlorpromazine-equivalent dose, supplementary stabilized inverse probability of treatment weighting (IPTW) Cox models with robust variance estimation, and marginally standardized risk differences with bootstrap confidence intervals. At 1 year, rehospitalization rates were 44.3% with OIS and 32.7% with TIS (log-rank p = 0.231); ER visit rates were 55.7% and 38.5%, respectively ( p = 0.105). For rehospitalization and ER visits, respectively, adjusted Cox hazard ratios (HRs) were 0.57 (95% CI 0.30–1.07; p = 0.081) and 0.58 (95% CI 0.33–1.01; p = 0.054), while IPTW HRs were 0.63 (0.35–1.15; p = 0.134) and 0.59 (0.33–1.03; p = 0.065). Adjusted risk differences (TIS minus OIS) were − 15.5% points (95% CI − 32.3 to 2.8) for rehospitalization and − 17.5 points (− 34.3 to 1.1) for ER visits. Although estimates numerically favored TIS, all comparisons remained statistically nonsignificant. Given the modest sample and potential residual confounding, findings are hypothesis-generating and require confirmation in larger prospective multicenter studies.

Authors

Institutions

Publication Details

Journal
BMC Psychiatry
Published
2026-11-18
DOI
https://doi.org/10.1186/s12888-026-08870-9
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

One-year healthcare utilization outcomes of two- versus one-injection start regimens of aripiprazole once-monthly in schizophrenia: a retrospective cohort study

Mustafa Kurt, Ali Taşdemir
4 links
BMC Psychiatry
Schizophrenia research and treatment
article

One-year healthcare utilization outcomes of two- versus one-injection start regimens of aripiprazole once-monthly in schizophrenia: a retrospective cohort study

Mustafa Kurt, Ali Taşdemir
article en

Abstract

The two-injection start (TIS) regimen of aripiprazole once-monthly (AOM) avoids the 14-day oral supplementation required with the one-injection start (OIS), but real-world evidence comparing their longer-term healthcare utilization outcomes in acutely hospitalized patients with schizophrenia remains limited. We retrospectively compared 131 patients hospitalized for an acute psychotic exacerbation of schizophrenia who initiated AOM via OIS ( n = 79) or TIS ( n = 52). Primary outcomes were time to first psychiatric rehospitalization and emergency room (ER) visit within 1 year. Analyses included Kaplan–Meier estimates, Cox models adjusted for age, sex, and baseline chlorpromazine-equivalent dose, supplementary stabilized inverse probability of treatment weighting (IPTW) Cox models with robust variance estimation, and marginally standardized risk differences with bootstrap confidence intervals. At 1 year, rehospitalization rates were 44.3% with OIS and 32.7% with TIS (log-rank p = 0.231); ER visit rates were 55.7% and 38.5%, respectively ( p = 0.105). For rehospitalization and ER visits, respectively, adjusted Cox hazard ratios (HRs) were 0.57 (95% CI 0.30–1.07; p = 0.081) and 0.58 (95% CI 0.33–1.01; p = 0.054), while IPTW HRs were 0.63 (0.35–1.15; p = 0.134) and 0.59 (0.33–1.03; p = 0.065). Adjusted risk differences (TIS minus OIS) were − 15.5% points (95% CI − 32.3 to 2.8) for rehospitalization and − 17.5 points (− 34.3 to 1.1) for ER visits. Although estimates numerically favored TIS, all comparisons remained statistically nonsignificant. Given the modest sample and potential residual confounding, findings are hypothesis-generating and require confirmation in larger prospective multicenter studies.

BMC Psychiatry
Karadeniz Technical University (TR)
Good health and well-being
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon